Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating paclitaxel with radiation therapy with or without trastuzumab in bladder cancer patients post-surgery, with phase 1/2 results comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-23